StockData
Sionna Therapeutics, Inc. logo

Sionna Therapeutics, Inc. (SION) stock

SIONNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$3.07−0.05 (-1.60%)

Close on Nov 17, 2026Market cap $138.80MP/E –Yield –

Sionna Therapeutics cash

Cash and short-term investments held at the end of each period.

Sionna Therapeutics's cash was $249.80M at Sep 30, 2026. For fiscal 2025 it was $58.45M, up 50.8% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$58.45M+50.8%
FY2024Dec 31, 2024$38.75M-1.9%
FY2023Dec 31, 2023$39.48M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$249.80M-23.1%
Q2 FY2026Jun 30, 2026$268.30M-20.5%
Q1 FY2026Mar 31, 2026$289.90M-18.3%
Q4 FY2025Dec 31, 2025$58.45M+50.8%
Q3 FY2025Sep 30, 2025$325.00M+809.1%
Q2 FY2025Jun 30, 2025$337.30M+666.2%
Q1 FY2025Mar 31, 2025$354.70M+328.6%
Q4 FY2024Dec 31, 2024$38.75M-1.9%
Q3 FY2024Sep 30, 2024$35.75M–
Q2 FY2024Jun 30, 2024$44.02M–
Q1 FY2024Mar 31, 2024$82.75M–
Q4 FY2023Dec 31, 2023$39.48M–

More Sionna Therapeutics figures

See a number that looks wrong?